| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,077,958 | 908,171 | 973,431 | 1,321,454 | | Cost of Revenue | (583,063) | 293,534 | 289,529 | 1,387,011 | | | Gross Profit | 1,661,021 | 614,637 | 683,902 | (65,557) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,297,570 | 357,561 | 378,926 | (525,724) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 37,265 | 33,754 | 36,612 | 48,196 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 326,186 | 223,322 | 268,364 | 411,971 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 84,060 | (43,265) | (81,493) | 42,256 | | Earnings Before Interest And Taxes | 414,131 | 180,057 | 186,871 | 454,227 | | Interest Expense | 211 | 2,092 | 1,200 | 478 | | Income Before Tax | 413,920 | 177,965 | 185,671 | 453,749 | | Income Tax Expense | 116,204 | 67,159 | 64,771 | 153,260 | | Minority Interest | 3,885 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 297,716 | 110,806 | 120,900 | 300,489 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 297,716 | 110,806 | 120,900 | 300,489 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $297,716 | $110,806 | $120,900 | $300,489 |
|
0.17% Nasdaq 
0.76 (0.68%) 
Income Statement
